CardioFocus Stock
CardioFocus is a biotechnology company that focuses on the advancement of ablation treatments for cardiac disorders.
Sign up today and learn more about CardioFocus Stock
Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.
About CardioFocus Stock
CardioFocus is a biotechnology company that focuses on the advancement of ablation treatments for cardiac disorders. The company specializes in providing electrophysiologists with innovative and effective tools that bring new levels of precision and control to the treatment of atrial fibrillation that focuses on developing, manufacturing, and investigating disposable fiber optic catheters for the visualization of the cardiac anatomy and the treatment of cardiac arrhythmias. CardioFocus was founded in 1990 and is headquartered in Marlborough, Massachusetts.
Funding History
| August 1998 | $2.6M |
|---|---|
| January 2000 | $9.6M |
| August 2001 | $1.8M |
| June 2004 | $10.7M |
| June 2008 | $9.1M |
| June 2009 | $5.9M |
| February 2011 | $30.6M |
| March 2011 | $5.0M |
| May 2013 | $11.0M |
| May 2014 | $2.4M |
| January 2015 | $32.0M |
| May 2016 | $8.0M |
| March 2017 | $20.2M |
| June 2018 | $21.0M |
| May 2019 | $55.0M |
| July 2020 | $12.0M |
| April 2022 | $4.0M |
Management
CEO & Board Member
Burke T Barrett
Executive Chairman
Paul LaViolette
VP Product Devlopment
Jerry Melsky
VP of Program Management
Rebecca Anderson
Bord of Directors
Michael Wasserman
VP of Operations
Mark Casey
Vice President of Operations
Brian K. Estabrook
Board of Directors
Bruce Robertson
Board Observer
Lisa Granick
Board Director
Paul LaViolette
Director, US Sales
Christopher F. Hallett
VP Sales & Marketing
Karl Firth
Press
prnewswire - Jul, 19 2022
CardioFocus Announces Pulsed Field Ablation Milestonesmedicaltubingandextrusion - Jun, 24 2021
CardioFocus wins Japan regulatory approval for HeartLight X3 systembioworld - Jun, 24 2021
Regulatory actions for June 23, 2021ow - Jun, 4 2021
Marlborough company signs $20M agreement with Chinese firmow - Jan, 16 2021
Marlborough company expands sales to Spain and Portugalow - May, 29 2020
CardioFocus promotes president to CEOmassdevice - May, 13 2020
CardioFocus wins FDA approval for HeartLight X3 endoscopic ablation systemmassdevice - Feb, 6 2020
CardioFocus seeks PMA supplement to launch HeartLight X3 endoscopic ablation systemwbjournal - Jun, 19 2019
CardioFocus places AFib system at 100th hospitalprnewswire - May, 29 2019
CardioFocus Secures $55 Million In Financingmassdevice - May, 29 2019
CardioFocus raises $55m for HeartLight ablation catheterswbjournal - Mar, 27 2019
CardioFocus hits triple-digit growth as regulatory approvals roll inwbjournal - Mar, 26 2019
CardioFocus wins European approval for new systemprnewswire - Jul, 12 2018
CardioFocus® Announces Full Commercial Launch of HeartLight® System in Japanprnewswire - Jun, 23 2018
GPB Capital Enters into $21 Million Debt Investment in CardioFocus®massdevice - Jun, 23 2018
GPB Capital puts $21m into CardioFocus for HeartLight catheter launchprnewswire - May, 9 2018
CardioFocus Announces Successful Live Case Featuring HeartLight® X3 Systemprnewswire - May, 8 2018
CardioFocus® Announces FDA Approval Of The Next-Generation HeartLight® Excalibur Balloon™ Designed For The Treatment Of Paroxysmal Atrial Fibrillation*prnewswire - Feb, 27 2018
CardioFocus Announces Initiation of HeartLight® X3 Clinical Evaluationmassdevice - Feb, 26 2018
CardioFocus launches trial for next-gen HeartLight devicefiercebiotech - Dec, 11 2017
CardioFocusprnewswire - Nov, 29 2017
CardioFocus® Completes Successful Controlled U.S. Commercial Launch of the HeartLight® Systemprnewswire - Mar, 29 2017
CardioFocus® Completes $20 Million Equity Financingprnewswire - Jan, 22 2017
CardioFocus® Announces Initial Clinical Evaluation of Next-Generation HeartLight® Excalibur Balloon™ Designed For the Treatment of Atrial Fibrillationwbjournal - Oct, 29 2016
CardioFocus adds chief commercial officerwbjournal - Apr, 18 2016
Marlborough co. gets FDA approval for laser heart treatmentmedcitynews - Apr, 14 2016
CardioFocus gets appoval for HeartLight endoscopic ablation systemprnewswire - Apr, 10 2016
CardioFocus' HeartLight® System Granted FDA Approval for Treatment of Atrial Fibrillation (AF)prnewswire - Nov, 5 2015
Ablation Catheters Market in the US 2015-2019businesswire - Nov, 4 2015
Research and Markets: Ablation Catheters Market in Europe 2015-2019 with Biosense Webster, Boston Scientific, Medtronic & St. Jude Medical Dominatingmassdevice - Sep, 29 2015
FDA to review HeartLight visually-guided ablation device from CardioFocusmassdevice - Sep, 29 2015
FDA approves Medtronic’s Evera MRI SureScan ICDmassdevice - Sep, 29 2015
China jacks up registration fees for medical devices, drugsmassdevice - Sep, 29 2015
Terumo looks to Olympus for GlideWire distributionfiercemedicaldevices - Sep, 29 2015
Nakashima, Teijin to establish JV to develop Japanese joint implantsmassdevice - Sep, 29 2015
Quanta portable dialysis device wins CE Mark | Medtech funding for the week of January 5, 2015massdevice - Sep, 29 2015
Quanta portable dialysis device wins CE Mark | Medtech funding for the week of January 5, 2015fiercemedicaldevices - Sep, 29 2015
CardioFocus raises $32M, partners in Japan ahead of pivotal atrial fib datamassdevice - Sep, 29 2015
CardioFocus raises $32m, inks Japanese distribution dealxconomy - Sep, 29 2015
CardioFocus Garners $11,000,000 New Financingxconomy - Sep, 29 2015
Alnylam Sued By Tekmira, Curis Cancer Drug Shows Results, Still River Gets $11.5M, & More Boston-Area Life Sciences Newsxconomy - Sep, 29 2015
February Freeze: Massachusetts Startup Funding Shrinks to $130.9 Mxconomy - Sep, 29 2015
Clouds, Clean Air, Cancer, and Cardio: Some Massachusetts Companies On the Risexconomy - Sep, 29 2015
CardioFocus Receives $5,000,000 New Fundingxconomy - Sep, 29 2015
CardioFocus Finds $30.6M for Atrial Fibrillation Treatmentbusinesswire - Sep, 29 2015
Research and Markets: United States Ablation Catheters Market 2015-2019 with Biosense Webster, Boston Scientific, Medtronic & St. Jude Medical Dominatingmassdevice - Sep, 29 2015
Obama taps cardiologist Califf to lead FDAmassdevice - Sep, 29 2015
FDA to review HeartLight visually-guided ablation device from CardioFocusxconomy - Sep, 29 2015
CardioFocus Lands $13,639,082 New Financing RoundEquityZen does not have an affiliation with, formal relationship with, or endorsement from any companies featured above. This profile is based on publicly available information and is intended to be informative in nature.
Some data provided by Crunchbase
EquityZen Recognized As:
